Using quality-improvement methods to reduce variation in surfactant administration

Laurel Bookman1, Rachel Troy, Martin McCaffrey

  • 1Division of Neonatology, Cincinnati Children's Hospital, MLC 7009, 3333 Burnet Avenue, Cincinnati, OH 45209, USA. laurelmed1@yahoo.com

Insights

Quality improvement methods significantly reduced the time to surfactant administration for premature infants. This enhanced timely treatment for respiratory distress syndrome in extremely low-birth-weight infants.

Area of Science:

  • Neonatal care
  • Quality improvement science
  • Respiratory medicine

Background:

  • Respiratory distress syndrome and chronic lung disease are common in extremely low-birth-weight infants.
  • Timely surfactant administration is crucial for improving respiratory outcomes in these vulnerable infants.

Purpose of the Study:

  • To evaluate the effectiveness of basic quality improvement methods in reducing the time to initial surfactant dose for premature infants.
  • To assess the impact of process changes on surfactant delivery timeliness.

Main Methods:

  • The study utilized Plan-Do-Study-Act cycles in a 48-bed neonatal intensive care unit (NICU).
  • Intervention involved surfactant administration in the delivery room with a dedicated respiratory therapist.
  • Data collected on infants born less than 27 weeks gestation.

Main Results:

  • Surfactant was administered in the delivery room for 95% of eligible infants post-intervention.
  • The mean time to initial surfactant dose decreased from 26 minutes to 10.2 minutes (p=0.0004).
  • Variation in the timing of surfactant administration was also reduced.

Conclusions:

  • Quality improvement initiatives can effectively enhance the timeliness of surfactant administration in NICUs.
  • These methods successfully reduced variability in treatment timing for premature infants.
  • Further research is recommended to validate these findings across diverse NICU settings.
Abstract

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Introduction to Statistical Process Control01:15

Introduction to Statistical Process Control

Statistical Process Control (SPC) is a method used to monitor and control quality within processes, particularly in manufacturing and service delivery, by employing statistical methods. SPC aims to distinguish between natural (common cause) variation and variation due to specific changes or events (special cause), allowing for timely improvements and sustained quality. The control chart, a pivotal tool in SPC, visually displays data over time alongside a central line of upper and lower control...
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...